With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Restoring P53's autonomous anti-cancer function through P53 mRNA delivery is a promising anti-tumor strategy. Yet, in tumors harboring mutant P53, the existing mutant P53 (Mutp53) would interferes ...
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...
Expanding demand for oligonucleotide therapeutics and GMP-grade reagents drives steady global market expansionAustin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Phosphoramidite Market Size & Growth Analysis ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON ...
As the Trump administration cuts federal funding for mRNA vaccine research, two top scientific efforts in New York are poised to continue forging mRNA-related breakthroughs aimed at fighting diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback